Denali Therapeutics Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$8,927,530
11 notices · 429,724 sh
Oct 2025 to Oct 2026
Reported ·
$1,300,167
7 sales · 0 buys
Oct 2025 to Sep 2026
The two figures cover different periods.
3 of 7 reported sales carry the 10b5-1 box. Together they are 0.04% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-09-04Chin Peter Scott, Chief Medical Officer$36,867
Form 4, 2026-09-09: sold 1,654 at $22.29 Form 4 ↗
2026-09-02NANCY THORNBERRY, Director$266,128
Form 4, 2026-09-04: sold 11,439 at $22.90 Form 4 ↗
2026-09-01ALEXANDER SCHUTH, COFO and Secretary$65,768
Form 4, 2026-09-03: sold 2,768 at $23.44 Form 4 ↗
2026-08-11Schuth Alexander O., COFO and Secretary$71,624
Form 4, 2026-08-13: sold 2,857 at $25.07 Form 4 ↗
2026-02-05CAROLE HO, Chief Medical Officer$801,394
2026-02-04CAROLE HO, Chief Medical Officer$3,176,970
2026-02-03CAROLE HO, Chief Medical Officer$3,324,060
2026-01-06Ho Carole, Chief Medical Officer$284,097
2026-01-06Schuth Alexander O., COFO and Secretary$284,097
Form 4, 2026-01-08: sold 17,218 at $16.50 Form 4 ↗
2026-01-06Watts Ryan J., President and CEO$580,767
Form 4, 2026-01-08: sold 35,198 at $16.50 Form 4 ↗
2025-12-04CAROLE HO, Chief Medical Officer$35,758